{"id":"https://openalex.org/W7147312967","doi":"https://doi.org/10.1080/09546634.2026.2647604","title":"Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study","display_name":"Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study","publication_year":2026,"publication_date":"2026-03-31","ids":{"openalex":"https://openalex.org/W7147312967","doi":"https://doi.org/10.1080/09546634.2026.2647604","pmid":"https://pubmed.ncbi.nlm.nih.gov/41918293"},"language":"en","primary_location":{"id":"doi:10.1080/09546634.2026.2647604","doi":"https://doi.org/10.1080/09546634.2026.2647604","is_oa":true,"landing_page_url":"https://doi.org/10.1080/09546634.2026.2647604","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/09546634.2026.2647604?needAccess=true","source":{"id":"https://openalex.org/S21432770","display_name":"Journal of Dermatological Treatment","issn_l":"0954-6634","issn":["0954-6634","1471-1753"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320449","host_organization_name":"Informa","host_organization_lineage":["https://openalex.org/P4310320449"],"host_organization_lineage_names":["Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Dermatological Treatment","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.tandfonline.com/doi/pdf/10.1080/09546634.2026.2647604?needAccess=true","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5020844397","display_name":"Jinshan Zhan","orcid":"https://orcid.org/0000-0003-1208-9383","observed_orcids":["https://orcid.org/0000-0003-1208-9383"]},"institutions":[{"id":"https://openalex.org/I4210146956","display_name":"Third Affiliated Hospital of Sun Yat-sen University","ror":"https://ror.org/04tm3k558","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210146956"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jinshan Zhan","raw_affiliation_strings":["Department of Dermatology, The Third Affiliated Hospital of Sun Yat-Sen University"],"raw_orcid":"https://orcid.org/0000-0003-1208-9383","affiliations":[{"raw_affiliation_string":"Department of Dermatology, The Third Affiliated Hospital of Sun Yat-Sen University","institution_ids":["https://openalex.org/I4210146956"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5132730628","display_name":"Ziyi Lei","orcid":"https://orcid.org/0009-0006-6846-5770","observed_orcids":["https://orcid.org/0009-0006-6846-5770"]},"institutions":[{"id":"https://openalex.org/I4210146956","display_name":"Third Affiliated Hospital of Sun Yat-sen University","ror":"https://ror.org/04tm3k558","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210146956"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Ziyi Lei","raw_affiliation_strings":["Department of Dermatology, The Third Affiliated Hospital of Sun Yat-Sen University"],"raw_orcid":"https://orcid.org/0009-0006-6846-5770","affiliations":[{"raw_affiliation_string":"Department of Dermatology, The Third Affiliated Hospital of Sun Yat-Sen University","institution_ids":["https://openalex.org/I4210146956"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028437963","display_name":"Yantao Xu","orcid":"https://orcid.org/0000-0002-5575-8332","observed_orcids":["https://orcid.org/0000-0002-5575-8332"]},"institutions":[{"id":"https://openalex.org/I4210146956","display_name":"Third Affiliated Hospital of Sun Yat-sen University","ror":"https://ror.org/04tm3k558","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210146956"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yantao Xu","raw_affiliation_strings":["Department of Dermatology, The Third Affiliated Hospital of Sun Yat-Sen University"],"raw_orcid":"https://orcid.org/0000-0002-5575-8332","affiliations":[{"raw_affiliation_string":"Department of Dermatology, The Third Affiliated Hospital of Sun Yat-Sen University","institution_ids":["https://openalex.org/I4210146956"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015579895","display_name":"Junjie Cen","orcid":"https://orcid.org/0000-0002-7503-8148","observed_orcids":["https://orcid.org/0000-0002-7503-8148","https://orcid.org/0000-0002-0980-7551"]},"institutions":[{"id":"https://openalex.org/I4210146956","display_name":"Third Affiliated Hospital of Sun Yat-sen University","ror":"https://ror.org/04tm3k558","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210146956"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Junjie Cen","raw_affiliation_strings":["Department of Dermatology, The Third Affiliated Hospital of Sun Yat-Sen University"],"raw_orcid":"https://orcid.org/0000-0002-0980-7551","affiliations":[{"raw_affiliation_string":"Department of Dermatology, The Third Affiliated Hospital of Sun Yat-Sen University","institution_ids":["https://openalex.org/I4210146956"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5132568230","display_name":"Xin Tang","orcid":"https://orcid.org/0000-0002-4451-8405","observed_orcids":["https://orcid.org/0000-0002-4451-8405"]},"institutions":[{"id":"https://openalex.org/I4210146956","display_name":"Third Affiliated Hospital of Sun Yat-sen University","ror":"https://ror.org/04tm3k558","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210146956"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xin Tang","raw_affiliation_strings":["Department of Dermatology, The Third Affiliated Hospital of Sun Yat-Sen University"],"raw_orcid":"https://orcid.org/0000-0002-4451-8405","affiliations":[{"raw_affiliation_string":"Department of Dermatology, The Third Affiliated Hospital of Sun Yat-Sen University","institution_ids":["https://openalex.org/I4210146956"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5083528149","display_name":"Miaojian Wan","orcid":"https://orcid.org/0000-0002-7468-6821","observed_orcids":["https://orcid.org/0000-0002-7468-6821"]},"institutions":[{"id":"https://openalex.org/I4210146956","display_name":"Third Affiliated Hospital of Sun Yat-sen University","ror":"https://ror.org/04tm3k558","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210146956"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Miaojian Wan","raw_affiliation_strings":["Department of Dermatology, The Third Affiliated Hospital of Sun Yat-Sen University"],"raw_orcid":"https://orcid.org/0000-0002-7468-6821","affiliations":[{"raw_affiliation_string":"Department of Dermatology, The Third Affiliated Hospital of Sun Yat-Sen University","institution_ids":["https://openalex.org/I4210146956"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5083528149"],"corresponding_institution_ids":["https://openalex.org/I4210146956"],"apc_list":null,"apc_paid":null,"fwci":21.795,"has_fulltext":true,"cited_by_count":6,"citation_normalized_percentile":{"value":0.99575271,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":99},"biblio":{"volume":"37","issue":"1","first_page":"2647604","last_page":"2647604"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9672999978065491,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9672999978065491,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11167","display_name":"Hair Growth and Disorders","score":0.03020000085234642,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/jak-inhibitors","display_name":"JAK inhibitors","score":0.8640000224113464},{"id":"https://openalex.org/keywords/alopecia-areata","display_name":"alopecia areata","score":1.0},{"id":"https://openalex.org/keywords/tofacitinib","display_name":"tofacitinib","score":0.8740000128746033},{"id":"https://openalex.org/keywords/baricitinib","display_name":"baricitinib","score":1.0},{"id":"https://openalex.org/keywords/ruxolitinib","display_name":"ruxolitinib","score":1.0},{"id":"https://openalex.org/keywords/ritlecitinib","display_name":"ritlecitinib","score":1.0},{"id":"https://openalex.org/keywords/post-marketing-safety","display_name":"post-marketing safety","score":0.7990000247955322},{"id":"https://openalex.org/keywords/adverse-event-signals","display_name":"adverse event signals","score":0.5490000247955322},{"id":"https://openalex.org/keywords/thrombocytosis","display_name":"thrombocytosis","score":0.8759999871253967},{"id":"https://openalex.org/keywords/deep-vein-thrombosis","display_name":"deep vein thrombosis","score":0.9639999866485596},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.8180000185966492},{"id":"https://openalex.org/keywords/fever","display_name":"fever","score":0.7070000171661377},{"id":"https://openalex.org/keywords/gastrointestinal-side-effects","display_name":"gastrointestinal adverse effects","score":0.7369999885559082},{"id":"https://openalex.org/keywords/creatine-kinase-elevation","display_name":"creatine kinase elevation","score":0.9449999928474426},{"id":"https://openalex.org/keywords/neuropsychiatric-side-effects","display_name":"neuropsychiatric adverse effects","score":0.8809999823570251},{"id":"https://openalex.org/keywords/autoimmune-adverse-events","display_name":"autoimmune adverse events","score":0.8140000104904175},{"id":"https://openalex.org/keywords/serious-adverse-events","display_name":"serious adverse events","score":0.7820000052452087},{"id":"https://openalex.org/keywords/time-to-onset","display_name":"time to onset","score":0.6899999976158142},{"id":"https://openalex.org/keywords/disproportionality-analysis","display_name":"disproportionality analysis","score":0.6579999923706055},{"id":"https://openalex.org/keywords/fda-adverse-event-reporting-system","display_name":"FDA Adverse Event Reporting System","score":0.4880000054836273}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9721999764442444},{"id":"https://openalex.org/C57658597","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Pharmacovigilance","level":3,"score":0.8579999804496765},{"id":"https://openalex.org/C3018359032","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Safety profile","level":3,"score":0.5562000274658203},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.44929999113082886},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.44510000944137573},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4246000051498413},{"id":"https://openalex.org/C2776112149","wikidata":"https://www.wikidata.org/wiki/Q7383611","display_name":"Ruxolitinib","level":4,"score":0.42329999804496765},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.38909998536109924},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.38119998574256897},{"id":"https://openalex.org/C12174686","wikidata":"https://www.wikidata.org/wiki/Q1058438","display_name":"Risk assessment","level":2,"score":0.353300005197525},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.35089999437332153},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.3447999954223633},{"id":"https://openalex.org/C2777105317","wikidata":"https://www.wikidata.org/wiki/Q4686710","display_name":"Adverse Event Reporting System","level":3,"score":0.32910001277923584},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3156000077724457},{"id":"https://openalex.org/C23276603","wikidata":"https://www.wikidata.org/wiki/Q158230","display_name":"Pharmacoepidemiology","level":3,"score":0.30889999866485596},{"id":"https://openalex.org/C2778886723","wikidata":"https://www.wikidata.org/wiki/Q3530324","display_name":"Tofacitinib","level":3,"score":0.2992999851703644},{"id":"https://openalex.org/C112392421","wikidata":"https://www.wikidata.org/wiki/Q903451","display_name":"Janus kinase","level":3,"score":0.28209999203681946},{"id":"https://openalex.org/C205545832","wikidata":"https://www.wikidata.org/wiki/Q17156455","display_name":"Young adult","level":2,"score":0.26589998602867126}],"mesh":[{"descriptor_ui":"D000075242","descriptor_name":"Janus Kinase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000506","descriptor_name":"Alopecia Areata","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001384","descriptor_name":"Azetidines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001952","descriptor_name":"Bridged-Ring Compounds","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009570","descriptor_name":"Nitriles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011358","descriptor_name":"Product Surveillance, Postmarketing","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011687","descriptor_name":"Purines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016907","descriptor_name":"Adverse Drug Reaction Reporting Systems","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D060735","descriptor_name":"Pharmacovigilance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1080/09546634.2026.2647604","doi":"https://doi.org/10.1080/09546634.2026.2647604","is_oa":true,"landing_page_url":"https://doi.org/10.1080/09546634.2026.2647604","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/09546634.2026.2647604?needAccess=true","source":{"id":"https://openalex.org/S21432770","display_name":"Journal of Dermatological Treatment","issn_l":"0954-6634","issn":["0954-6634","1471-1753"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320449","host_organization_name":"Informa","host_organization_lineage":["https://openalex.org/P4310320449"],"host_organization_lineage_names":["Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Dermatological Treatment","raw_type":"journal-article"},{"id":"pmid:41918293","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41918293","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of dermatological treatment","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:821bdc64625448259ee7e406aa38a5b8","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/821bdc64625448259ee7e406aa38a5b8","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Dermatological Treatment, Vol 37, Iss 1 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1080/09546634.2026.2647604","doi":"https://doi.org/10.1080/09546634.2026.2647604","is_oa":true,"landing_page_url":"https://doi.org/10.1080/09546634.2026.2647604","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/09546634.2026.2647604?needAccess=true","source":{"id":"https://openalex.org/S21432770","display_name":"Journal of Dermatological Treatment","issn_l":"0954-6634","issn":["0954-6634","1471-1753"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320449","host_organization_name":"Informa","host_organization_lineage":["https://openalex.org/P4310320449"],"host_organization_lineage_names":["Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Dermatological Treatment","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7147312967.pdf","grobid_xml":"https://content.openalex.org/works/W7147312967.grobid-xml"},"referenced_works_count":44,"referenced_works":["https://openalex.org/W2019214729","https://openalex.org/W2027006196","https://openalex.org/W2044168067","https://openalex.org/W2046584449","https://openalex.org/W2049804077","https://openalex.org/W2136521846","https://openalex.org/W2145557630","https://openalex.org/W2540499968","https://openalex.org/W2596736776","https://openalex.org/W2773759136","https://openalex.org/W2787750967","https://openalex.org/W2789004799","https://openalex.org/W2883519784","https://openalex.org/W2890386733","https://openalex.org/W2912414063","https://openalex.org/W2913263286","https://openalex.org/W2969631385","https://openalex.org/W2990841231","https://openalex.org/W2995517661","https://openalex.org/W3016239356","https://openalex.org/W3080826108","https://openalex.org/W3080915563","https://openalex.org/W3092033766","https://openalex.org/W3115999216","https://openalex.org/W3133127295","https://openalex.org/W3135431952","https://openalex.org/W3204327959","https://openalex.org/W3206870195","https://openalex.org/W4210529991","https://openalex.org/W4220917957","https://openalex.org/W4289886667","https://openalex.org/W4317951857","https://openalex.org/W4362472602","https://openalex.org/W4362635255","https://openalex.org/W4365517205","https://openalex.org/W4367857058","https://openalex.org/W4383535508","https://openalex.org/W4385840921","https://openalex.org/W4388484257","https://openalex.org/W4391130620","https://openalex.org/W4407071862","https://openalex.org/W4407911704","https://openalex.org/W4410167181","https://openalex.org/W4417106580"],"related_works":["https://openalex.org/W4362522296","https://openalex.org/W4367857058","https://openalex.org/W7212443947","https://openalex.org/W4292883993","https://openalex.org/W7138943317","https://openalex.org/W4413227942","https://openalex.org/W4388420435","https://openalex.org/W7161795484","https://openalex.org/W4399197199","https://openalex.org/W4411732547"],"abstract_inverted_index":{"To":[0],"characterize":[1],"and":[2,22,47,59,77,88,94,98,103,117,126,175],"compare":[3],"the":[4,36,121,134,145],"post-marketing":[5,161],"safety":[6,67,162],"profiles":[7],"of":[8,147],"Janus":[9],"kinase":[10],"(JAK)":[11],"inhibitors":[12,29,155],"used":[13,156],"in":[14,30,157,179],"alopecia":[15],"areata":[16],"(AA),":[17],"including":[18],"tofacitinib,":[19],"baricitinib,":[20],"ruxolitinib,":[21,118],"ritlecitinib.":[23],"METHODS:":[24],"Reports":[25],"associated":[26,82],"with":[27,83,92,100,112],"JAK":[28,154],"AA":[31,158],"(2015-2025)":[32],"were":[33,62,109,138],"retrieved":[34],"from":[35],"FDA":[37],"Adverse":[38],"Event":[39],"Reporting":[40],"System":[41],"(FAERS).":[42],"Disproportionality":[43],"analyses":[44,61],"utilized":[45],"within-class":[46],"external":[48],"non-JAK":[49],"comparisons.":[50],"Additionally,":[51],"time-to-onset":[52],"(TTO),":[53],"serious":[54,136],"adverse":[55],"event":[56],"(SAE)":[57],"profiles,":[58],"sensitivity":[60],"assessed.":[63],"RESULTS:":[64],"=":[65],"20]),":[66],"signals":[68,74],"varied":[69],"across":[70],"agents.":[71],"Tofacitinib":[72],"showed":[73],"involving":[75],"neuropsychiatric":[76],"autoimmune":[78],"events;":[79],"baricitinib":[80],"was":[81],"thrombocytosis,":[84],"deep":[85],"vein":[86],"thrombosis,":[87],"breast":[89],"cancer;":[90],"ruxolitinib":[91],"pyrexia":[93],"elevated":[95],"blood":[96],"cholesterol;":[97],"ritlecitinib":[99],"gastrointestinal":[101],"events":[102],"creatine":[104],"phosphokinase":[105],"elevation.":[106],"TTO":[107],"patterns":[108,163],"also":[110],"heterogeneous,":[111],"earlier":[113],"onset":[114,130],"for":[115,124,131],"tofacitinib":[116],"clustering":[119],"within":[120],"first":[122],"month":[123],"ritlecitinib,":[125],"a":[127],"relatively":[128],"delayed":[129],"baricitinib.":[132],"Across":[133],"class,":[135],"outcomes":[137,149],"most":[139],"commonly":[140],"related":[141],"to":[142],"infections,":[143],"although":[144],"distribution":[146],"clinical":[148,180],"differed":[150],"by":[151,167],"agent.":[152],"CONCLUSIONS:":[153],"demonstrated":[159],"heterogeneous":[160],"not":[164],"fully":[165],"captured":[166],"class-level":[168],"warnings.":[169],"These":[170],"findings":[171],"support":[172],"agent-specific":[173],"surveillance":[174],"individualized":[176],"risk":[177],"assessment":[178],"practice.":[181]},"counts_by_year":[{"year":2026,"cited_by_count":6}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-04-02T00:00:00"}